colestipol has been researched along with Elevated Cholesterol in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (56.04) | 18.7374 |
1990's | 33 (36.26) | 18.2507 |
2000's | 6 (6.59) | 29.6817 |
2010's | 1 (1.10) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hegele, RA; Lewis, GF; Xiao, C | 1 |
Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM | 1 |
Brown, BG; Brunzell, JD; Hokanson, JE; Motulsky, AG; Zambon, A | 1 |
Stamler, J | 1 |
Chernoff, SB; DeCoursey, S; Dujovne, CA; Jackson, B; Krehbiel, P; Taylor, H | 1 |
Glueck, CJ | 2 |
Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A | 1 |
Canzler, H | 1 |
Düntsch, G | 2 |
Faruqui, AM; Thurmond, MS; Wenger, J; Wenger, NK | 1 |
Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM | 1 |
Berns, L; Eder, HA; Goodman, DS; Seplowitz, AH; Smith, FR | 1 |
Kane, JP; Malloy, MJ | 2 |
Saudek, CD | 1 |
Mordasini, R; Oster, P; Riesen, W; Riva, G | 1 |
Basich, P; Schonfeld, G; Witztum, J | 1 |
Esente, P; Gensini, G; Nash, DT | 1 |
Untereker, WJ | 1 |
Morimoto, Y | 1 |
Heidenheim, P; Huff, MW; Lindsay, R; Mills, D; Munoz, C; Spence, JD; Viswanatha, A; Wolfe, B | 1 |
Ginsberg, HN | 1 |
Davidson, MH; Demke, DM; Dujovne, CA; Eckert, SM; Ginsberg, D; Goldberg, AC; Hodis, HN; Hughes, TA; Insull, W; Kane, JP | 1 |
Davidson, MH; Dujovne, CA; Goris, GB; Oliphant, TH; Phillips, JC; Schrott, HG; Shawaryn, GG; Stein, EA | 1 |
Kłosiewicz-Latoszek, L; Nowicka, G; Szostak, WB | 1 |
Cummings, MH; Watts, GF | 1 |
Albers, JJ; Brown, BG; Dowdy, A; Fisher, LD; Hillger, LA; Sniderman, AD; Stewart, BF; Zhao, XQ | 1 |
Hathaway, SC; Paat, JJ; Paterson, RW; Steele, GH; Wong, JG | 1 |
Fowler, G; Lyons, D; Petrie, JC; Webster, J | 1 |
de Koning Gans, HJ; Gørbitz, C; Harrison, EM; Ose, L; Tonstad, S | 1 |
McKenney, JM | 1 |
Davidson, C; Davidson, D; Iversen, SA | 1 |
Caslake, MJ; Colquhoun, I; Gaw, A; Griffin, BA; Lindsay, GM; Lorimer, AR; Murray, EF; Packard, CJ; Shepherd, J; Wheatley, DJ | 1 |
Hiatt, J; Schectman, G | 1 |
Abe, Y; Ballantyne, CM; Dunn, K; Gotto, AM; Hackman, A; Insull, W; Pownall, H; Smith, L | 1 |
Farmer, JA; Gotto, AM | 1 |
Oster, G; Thompson, D | 1 |
Hannuksela, ML; Kervinen, K; Kesäniemi, YA; Korhonen, T; Savolainen, MJ; Seppänen, S | 1 |
Hodis, HN; LaBree, L; Liu, C; Mack, WJ; Selzer, RH | 1 |
Susekov, AV | 1 |
Steinmetz, KL | 1 |
Desager, JP; Harvengt, C | 1 |
Schonfeld, G; Weidman, SW; Witztum, JL | 1 |
Grundy, SM | 1 |
Dorr, AE; Gundersen, K; Martin, WB; Schneider, JC; Spencer, TW | 1 |
Baggio, G; Baiocchi, MR; Baldo, G; Briani, G; Crepaldi, G; Fellin, R; Manzato, E | 1 |
Martz, BL | 1 |
Ruoff, G | 1 |
Heuck, CC; Mordasini, R; Oster, P; Raetzer, H; Schellenberg, B; Schlierf, G; Twelsick, F | 1 |
Debry, G; Drouin, P; Lambert, D; Mejean, L; Sauvanet, JP | 1 |
Cocuzza, E; Conti, F; De Simone, R; Lovati, MR; Sirtori, CR; Sirtori, M | 1 |
Glueck, CJ; Mellies, MJ; Roginsky, MS; Tsang, RC | 1 |
Bandisode, MS; Boshell, BR | 1 |
Grundy, SM; Mok, HY | 1 |
Fisher, AC; Wallenstein, S | 1 |
Fallat, RW; Glueck, CJ; Mellies, MJ; Tsang, RC | 1 |
Kudchodkar, B; Nestel, PJ | 1 |
Lemmens, P; Muls, E | 1 |
Parfitt, A; Simons, J; Simons, LA | 1 |
Andreadis, NA; Greenland, P; Haskell, WL; Hunninghake, D; Manchester, RA; Probstfield, JL; Schectman, G; Superko, HR; West, NH | 1 |
Ito, MK; Morreale, AP | 1 |
Schon, P | 1 |
Eisenberg, JM; Glick, H; Jacobson, TA; Kinosian, B; Koffer, H; Schulman, KA; Willian, MK | 1 |
Ast, M; Frishman, WH | 1 |
Barth, JD; Kruisbrink, OA; Van Dijk, AL | 1 |
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Mack, WJ; Pogoda, JM; Sanmarco, ME | 1 |
Baker, AL; Chow, MJ; Hay, RV; Rosenson, RS | 1 |
Helve, E; Karjalainen, K; Ojala, JP; Tarkkanen, A; Tikkanen, MJ | 1 |
Adams, M; Dell, RB; Goldberg, IJ; Goodman, DS; Holleran, S; Palmer, RH; Ramakrishnan, R | 1 |
Day, CE | 1 |
Potts, JF; Setness, PA | 1 |
Doorenbos, H; Koopman, BJ; Smit, N; van der Molen, JC; van Doormaal, JJ; Wolthers, BG | 1 |
Anding, RH; Lueg, MC | 1 |
Eisenberg, JM; Kinosian, BP | 1 |
Hunninghake, DB | 1 |
Nikkilä, EA; Tikkanen, MJ | 1 |
Havel, RJ; Kane, JP | 1 |
Chernoff, SB; Dujovne, CA; Krehbiel, P | 1 |
Grundy, SM; Vega, GL | 1 |
Appel, GB; Blum, C; Gelfand, J; Valeri, A | 1 |
Crouse, JR | 1 |
Bilheimer, DW | 1 |
Bassett, D; Gross, MD; Lynn, MD; Shapiro, B | 1 |
Anderson, EC; Davis, TA; Ginsburg, AV; Goldberg, AP | 1 |
15 review(s) available for colestipol and Elevated Cholesterol
Article | Year |
---|---|
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
Topics: Colestipol; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Kinetics; Polyamines; Protein Binding | 1980 |
Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
Topics: Arteriosclerosis; Cholesterol; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Niacin; Nicotinic Acids; Phenols; Polyamines; Probucol | 1982 |
Treatment of hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine | 1982 |
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin | 1995 |
Impact of intensive lipid modulation on angiographically defined coronary disease: clinical implications.
Topics: Angiography; Clinical Trials as Topic; Colestipol; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Lovastatin; Niacin; Random Allocation | 1994 |
Choosing the right lipid-regulating agent. A guide to selection.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides | 1996 |
Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature.
Topics: Age Factors; Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Risk Factors; Sex Factors; Treatment Outcome | 1992 |
[Substantiation of increasing doses of statins in clinical practice].
Topics: Adult; Aged; Angiography; Animals; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Clinical Trials as Topic; Colestipol; Coronary Disease; Dogs; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lovastatin; Male; Meta-Analysis as Topic; Middle Aged; Primates; Prospective Studies; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Time Factors | 2001 |
Colesevelam hydrochloride.
Topics: Allylamine; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents | 2002 |
Treatment of hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides | 1977 |
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Cost-Benefit Analysis; Drug Therapy, Combination; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol; Sensitivity and Specificity | 1990 |
Bile acid sequestrants.
Topics: Chemical Phenomena; Chemistry; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lipoproteins, VLDL; Polyamines; Resins, Plant | 1990 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides | 1988 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
28 trial(s) available for colestipol and Elevated Cholesterol
Article | Year |
---|---|
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy.
Topics: Adult; Analysis of Variance; Apolipoproteins B; Colestipol; Coronary Angiography; Coronary Stenosis; Drug Therapy, Combination; Dyslipidemias; Genetic Predisposition to Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Niacin; Pharmacogenetics; Treatment Outcome | 2006 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
Low-dose colestipol plus probucol for hypercholesterolemia.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Constipation; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Phenols; Polyamines; Probucol | 1984 |
Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Topics: Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Polyamines; Triglycerides | 1981 |
[Behavior of high-density lipoproteins in drug lipid-lowering treatment].
Topics: Adult; Apoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Clofibric Acid; Colestipol; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Male; Middle Aged; Probucol | 1982 |
Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia.
Topics: Adult; Aged; Blood Pressure; Colestipol; Double-Blind Method; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Patient Compliance; Psyllium; Quality of Life | 1995 |
The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Colestipol; Dosage Forms; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Tablets; Triglycerides | 1995 |
Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
Topics: Apolipoproteins; Cholesterol, LDL; Colestipol; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged | 1995 |
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Niacin; Treatment Outcome | 1994 |
Colestipol at varying dosage intervals in the treatment of moderate hypercholesterolaemia.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Triglycerides | 1994 |
Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia.
Topics: Adult; Aged; Cholesterol; Colestipol; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged | 1993 |
The acceptability of resin therapy to patients attending a hospital lipid clinic.
Topics: Adolescent; Adult; Aged; Anion Exchange Resins; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Cross-Over Studies; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Inpatients; Male; Middle Aged; Surveys and Questionnaires | 1995 |
Effects of colestipol alone and in combination with simvastatin on apolipoprotein B metabolism.
Topics: Adult; Apolipoproteins B; Colestipol; Drug Combinations; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Simvastatin | 1996 |
The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
Topics: Adult; Apolipoproteins E; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Colestipol; Female; Glycoproteins; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Phenotype; Triglycerides | 1999 |
Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography.
Topics: Adult; Carotid Artery, Common; Carotid Stenosis; Colestipol; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Observer Variation; Prognosis; Reproducibility of Results; Tunica Intima; Ultrasonography; Video Recording | 2000 |
Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Topics: Adolescent; Adult; Child; Cholesterol; Clinical Trials as Topic; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Placebos; Polyamines; Triglycerides; Xanthomatosis | 1976 |
Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos; Polyamines | 1978 |
Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Polyamines; Time Factors; Triglycerides | 1978 |
Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study.
Topics: Adult; Cholesterol; Colestipol; Family Practice; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Michigan; Middle Aged; Polyamines; Retrospective Studies | 1978 |
[Type II hyperlipoproteinemia: treatment with colestipol and procetophen].
Topics: Adult; Aged; Colestipol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Polyamines; Propionates | 1978 |
Hypocholesterolemic activity of colestipol in diabetes.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Clinical Trials as Topic; Colestipol; Depression, Chemical; Diabetes Complications; Diabetes Mellitus; Drug Interactions; Female; Humans; Hypercholesterolemia; Insulin; Male; Middle Aged; Phenformin; Placebos; Polyamines; Sulfonylurea Compounds; Triglycerides | 1975 |
Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
Topics: Anticholesteremic Agents; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Colestipol; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lovastatin; Simvastatin; Treatment Outcome; Triglycerides | 1992 |
Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia.
Topics: Adult; Cholesterol; Colestipol; Double-Blind Method; Drug Evaluation; Female; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Triglycerides; United States | 1992 |
Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia.
Topics: Adult; Anticholesteremic Agents; Colestipol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin; Sleep Wake Disorders | 1990 |
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.
Topics: Adult; Apolipoproteins; Cholesterol; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Niacin; Radiography | 1990 |
Controlled studies of the efficacy and safety of combined probucol-colestipol therapy.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Phenols; Polyamines; Probucol; Prospective Studies; Time Factors | 1986 |
Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
Topics: Aged; Anticholesteremic Agents; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Kinetics; Lipids; Lovastatin; Male; Middle Aged; Naphthalenes; Polyamines | 1987 |
Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nephrotic Syndrome; Phenols; Polyamines; Probucol | 1986 |
48 other study(ies) available for colestipol and Elevated Cholesterol
Article | Year |
---|---|
Treatment of Severe Hypercholesterolemia in a Woman With Advanced Primary Sclerosing Cholangitis.
Topics: Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colestipol; Facial Dermatoses; Female; Hand Dermatoses; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoprotein-X; Plasma Exchange; Severity of Illness Index; Skin Diseases; Ursodeoxycholic Acid; Xanthomatosis | 2017 |
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2004 |
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides | 1983 |
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines | 1983 |
[Drug therapy of hypercholesterinemias (author's transl)].
Topics: Adult; Bezafibrate; Cholestyramine Resin; Clofibric Acid; Colestipol; Dextrothyroxine; Fenofibrate; Humans; Hypercholesterolemia; Neomycin; Nicotinic Acids; Sitosterols | 1980 |
[Long-term therapy of hypercholesteremia in diabetics with colestipol].
Topics: Aged; Cholesterol; Colestipol; Diabetes Mellitus; Female; Humans; Hypercholesterolemia; Long-Term Care; Male; Middle Aged; Polyamines; Triglycerides | 1981 |
Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
Topics: Adult; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Male; Polyamines | 1981 |
Hyperlipidemia - a diabetic emergency.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Colestipol; Diabetes Complications; Diagnosis, Differential; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Middle Aged; Nicotinic Acids; Triglycerides | 1982 |
Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
Topics: Adult; Aged; Apoproteins; Cholesterol; Colestipol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Phenols; Polyamines; Probucol; Triglycerides | 1982 |
Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography.
Topics: Cholesterol; Colestipol; Coronary Angiography; Coronary Disease; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Polyamines; Risk; Triglycerides | 1982 |
Treatment of hypercholesterolemia. Can it retard atherogenesis?
Topics: Cholesterol; Colestipol; Coronary Angiography; Coronary Disease; Humans; Hypercholesterolemia; Polyamines; Risk | 1982 |
[Adrenocortical functions in hypercholesterolemic patients; effect of long-term treatment with colestipol-HCl (author's transl)].
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Aged; Cholesterol; Colestipol; Female; Humans; Hydrocortisone; Hypercholesterolemia; Male; Middle Aged; Polyamines | 1981 |
Colestipol therapy and selected vitamin and mineral levels in children.
Topics: Adolescent; Child; Child, Preschool; Colestipol; Female; Folic Acid; Humans; Hypercholesterolemia; Male; Polyamines; Vitamin A; Vitamin E | 1980 |
[Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
Topics: Adult; Aged; Colestipol; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged | 1993 |
Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
Topics: Administration, Oral; Bezafibrate; Bilirubin; Colestipol; Gilbert Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Liver; Liver Function Tests; Lovastatin; Male; Middle Aged; Pravastatin; Pyrazines; Simvastatin | 1994 |
New guidelines for managing hypercholesterolemia. National Cholesterol Education Program.
Topics: Algorithms; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Oxidoreductases; Risk Factors | 1993 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol | 1993 |
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Colestipol; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Niacin; Peripheral Vascular Diseases; Retrospective Studies; Treatment Outcome; Triglycerides | 1996 |
Levels of soluble cell adhesion molecules in patients with dyslipidemia.
Topics: Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cell Adhesion Molecules; Colestipol; Drug Therapy, Combination; E-Selectin; Endothelium, Vascular; Enzyme Inhibitors; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Intercellular Adhesion Molecule-1; Lovastatin; Male; Middle Aged; Pyrroles; Risk Factors; Simvastatin; Solubility; Vascular Cell Adhesion Molecule-1 | 1996 |
The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
Topics: Adult; Cholesterol; Colestipol; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Polyamines; Triglycerides | 1976 |
Drug management of hypercholesterolemia.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols | 1979 |
[A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Topics: Adolescent; Child; Cholesterol; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Phospholipids; Polyamines | 1978 |
New microporous cholestyramine analog for treatment of hypercholesterolemia.
Topics: Adult; Aged; Cholestyramine Resin; Cholic Acids; Colestipol; Constipation; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Suspensions | 1978 |
Plasma 25-hydroxy-vitamin D in familial hypercholesterolemic children receiving colestipol resin.
Topics: Adolescent; Adult; Calcium; Child; Cholesterol; Colestipol; Humans; Hydroxycholecalciferols; Hypercholesterolemia; Phosphates; Polyamines | 1978 |
Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Clofibrate; Colestipol; Drug Therapy, Combination; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Middle Aged; Phytosterols; Polyamines; Steroids; Triglycerides | 1977 |
The analysis of the two-period repeated measurements crossover design with application to clinical trials.
Topics: Analysis of Variance; Clofibrate; Colestipol; Griseofulvin; Humans; Hypercholesterolemia; Male; Research | 1977 |
[Colestipol by hypercholesteremia in diabetics].
Topics: Colestipol; Diabetes Mellitus; Humans; Hypercholesterolemia; Polyamines | 1977 |
Treatment of hyperlipidemias in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Triglycerides | 1977 |
Plasma squalene as an index of cholesterol synthesis.
Topics: Adult; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Squalene | 1975 |
[Experiences with a new cholesterolemia-lowering resin, Colestipol (U-26, 597 A. Upjohn)].
Topics: Adult; Aged; Colestipol; Drug Evaluation; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Polyamines | 1975 |
Acceptability of cholestyramine and colestipol formulations in three common vehicles.
Topics: Adult; Chemistry, Pharmaceutical; Cholestyramine Resin; Colestipol; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Hypercholesterolemia; Male; Prospective Studies; Random Allocation; Taste | 1991 |
Bile acid sequestrants and cholesterol.
Topics: Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Polyamines | 1990 |
Therapy for hypercholesterolemia; standardization of cholesterol measurements.
Topics: Cholesterol; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Hypercholesterolemia; Reference Standards; Thyroid Function Tests | 1990 |
Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis.
Topics: Blood Viscosity; Cholesterol; Cholesterol, Dietary; Colestipol; Combined Modality Therapy; Female; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Middle Aged; Plasma Exchange; Recurrence; Syndrome; Xanthomatosis | 1990 |
Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
Topics: Adult; Aged; Cholesterol, LDL; Colestipol; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Polyamines; Probucol; Triglycerides | 1990 |
Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.
Topics: Adult; Aged; Cholesterol; Colestipol; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Metabolic Clearance Rate; Middle Aged; Niacin | 1990 |
Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Coturnix; Diet, Atherogenic; Disease Models, Animal; Hypercholesterolemia; Male; Polyamines; Therapeutic Equivalency | 1990 |
Elevated cholesterol levels. How to individualize treatment.
Topics: Adult; Behavior Therapy; Cholesterol, Dietary; Colestipol; Coronary Disease; Exercise; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors; Smoking; Wine | 1990 |
Hydroxycholesterols in serum from hypercholesterolaemic patients with and without bile acid sequestrant therapy.
Topics: Adult; Bile Acids and Salts; Colestipol; Female; Humans; Hydroxycholesterols; Hypercholesterolemia; Intestinal Absorption; Lipids; Male; Middle Aged; Polyamines | 1989 |
Hypercholesterolemia: new values, new strategies.
Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin | 1986 |
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking | 1988 |
Current and new therapy for hypercholesterolemia.
Topics: Anticholesteremic Agents; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol | 1988 |
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors | 1988 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Polyamines; Time Factors; Triglycerides | 1987 |
Lipoprotein fractions and receptors: a role for probucol?
Topics: Anticholesteremic Agents; Biological Transport; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, HDL; Lipoproteins, IDL; Lipoproteins, VLDL; Lovastatin; Naphthalenes; Phenols; Probucol; Receptors, LDL | 1986 |
The influence of hypercholesterolaemia on the adrenal uptake and metabolic handling of 131I-6 beta-iodomethyl-19-norcholesterol (NP-59).
Topics: 19-Iodocholesterol; Adrenal Cortex; Animals; Bile; Cholesterol; Colestipol; Disease Models, Animal; Esters; Humans; Hypercholesterolemia; Iodine Radioisotopes; Male; Niacin; Rabbits; Radionuclide Imaging; Triglycerides | 1986 |
Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia.
Topics: Adult; Aged; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Diet, Reducing; Female; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Time Factors; Triglycerides | 1985 |